Skill Profile
Formulation
"The observable action of selecting, combining, and optimising the components of a product — active ingredients, excipients, carriers, and processing parameters — through systematic experimental design and analytical testing — in order to produce a stable, effective, and manufacturable formulation that meets defined performance, safety, and regulatory specifications."
YOUR SKILLS
Problems This Skill Solves
- Drug candidates with poor bioavailability — formulation science converts a promising active pharmaceutical ingredient (API) with poor solubility or permeability into a dosage form that can be absorbed reliably by the patient (e.g., nanoparticle delivery, solid dispersions, lipid-based systems)
- Unstable products that degrade during storage — formulation work identifies excipient combinations, packaging configurations, and manufacturing conditions that protect the API from oxidation, hydrolysis, photodegradation, and microbial contamination
- Unscalable laboratory preparations — formulation scientists bridge the gap between small-scale laboratory preparations and commercially manufacturable products, identifying process parameters that are robust at manufacturing scale
- Patient adherence barriers — formulation work creates dosage forms that are acceptable to patients: controlled-release tablets that reduce dosing frequency, taste-masked paediatric liquids, transdermal patches that replace injections, or modified-release capsules that reduce gastrointestinal side effects
Tools Used
Roles That Use This Skill
1 total · 1 industryThis skill is concentrated in one industry.
Psychology / Healthcare / NHS Mental Health
"Formulation quality is mainly about ingredient selection — choose the right active ingredient and excipients, and the product performs."
Ingredient selection determines feasibility, not performance. The formulation must also achieve physical stability, bioavailability, patient acceptability, manufacturing scalability, and compatibility with intended storage and transport conditions. Many ingredient combinations that are theoretically correct produce formulations that are unstable, unacceptable, or impossible to manufacture reproducibly at scale.
Research & Outlook
Formulation science is being transformed by continuous manufacturing technologies that replace batch processes with integrated, real-time monitored production lines — requiring formulation scientists to understand process analytical technology (PAT) and real-time release testing frameworks. AI and machine learning are being applied to formulation screening, using databases of known excipient interactions and physicochemical property relationships to predict formulation performance before laboratory experiments begin. Advanced drug delivery systems — including mRNA lipid nanoparticles (as validated by COVID-19 vaccines), antibody-drug conjugates, and cell therapy formulations — are expanding the scope of formulation science beyond traditional small molecules into biological and gene therapy products, requiring entirely new analytical characterisation toolkits.
See This Skill In Action
Watch a professional demonstrate Formulation in a real working environment — what it looks like, how it's applied, and why it matters.
Science / Pharmaceutical & Chemical
Formulation
Also Known As
Growth Path
Can prepare standard dosage forms (tablets, capsules, solutions, suspensions) following an existing formulation protocol. Conducts basic analytical tests — dissolution, assay, physical appearance — and records results in an ELN. Understands the role of key excipients (binders, disintegrants, lubricants, preservatives) in pharmaceutical formulations.
Independently designs and executes formulation development studies using DoE principles, including screening and optimisation experiments. Interprets stability data, identifies degradation pathways, and proposes formulation modifications to address stability failures. Contributes to regulatory submission documents (Module 3) and tech transfer packages.
Leads formulation development programmes from API receipt through to clinical or commercial manufacturing, defining the Quality Target Product Profile (QTPP) and Design Space. Authors ICH Q8-compliant pharmaceutical development reports. Manages cross-functional teams including analytical chemistry, manufacturing, and regulatory affairs. Represents formulation strategy in regulatory meetings and responds to agency questions on drug product quality.
How to Practise
- 1.Study the physicochemical properties that drive formulation decisions — solubility, pKa, log P, polymorphism, hygroscopicity, and particle size — and how each property influences the choice of dosage form and excipients. Aulton's Pharmaceutics is the standard reference text.
- 2.Complete laboratory-based formulation experiments: prepare simple tablet, capsule, and suspension formulations; conduct dissolution testing; and perform basic stability assessments to build intuition for how variables interact.
- 3.Apply Design of Experiments methodology to a formulation problem: define the critical quality attributes (CQAs), identify the critical material attributes (CMAs) and critical process parameters (CPPs), design a screening study, and interpret the results using response surface methodology.
- 4.Study ICH Q8 (Pharmaceutical Development), Q9 (Quality Risk Management), and Q10 (Pharmaceutical Quality System) — the Quality by Design (QbD) framework that defines how regulatory agencies expect formulation development to be documented.
How to Prove
- ·Published or internal formulation development reports demonstrating the systematic identification of a design space — including DoE data, analytical characterisation, and stability data — for a product progressed to clinical or commercial manufacture
- ·Patent applications or granted patents with named inventorship on formulation compositions or manufacturing processes
- ·Regulatory submission contributions: Module 3 (Quality) sections of an IND, NDA, ANDA, or MAA dossier covering pharmaceutical development (ICH Q8) and drug product specifications
- ·Successful tech transfer documentation: a formulation developed at laboratory scale transferred to pilot or commercial manufacturing with a documented comparability exercise